Chelapram K. Firoz

Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease

Nasimudeen R. Jabir, Chelapram K. Firoz, Farid Ahmed et al. · Immunological Investigations · 2017 · 26 citations

A putative association of interleukin‐10 promoter polymorphisms with cardiovascular disease

Shams Tabrez, Murtaza Ali, Nasimudeen R. Jabir et al. · IUBMB Life · 2017 · 26 citations · Full text

Assessment of genetic diversity in IL-6 and RANTES promoters and their level in Saudi coronary artery disease patients

Nasimudeen R. Jabir, Chelapram K. Firoz, Mohammad Amjad Kamal et al. · Journal of Clinical Laboratory Analysis · 2016 · 25 citations · Full text

Neopterin: An immune biomarker of coronary artery disease and its association with other <scp>CAD</scp> markers

Chelapram K. Firoz, Nasimudeen R. Jabir, Mohammad Amjad Kamal et al. · IUBMB Life · 2015 · 23 citations · Full text

Assessment of IL‐18 Serum Level and Its Promoter Polymorphisms in the Saudi Coronary Artery Disease (CAD) Patients

Nasimudeen R. Jabir, Chelapram K. Firoz, Mohammad Amjad Kamal et al. · Journal of Cellular Biochemistry · 2017 · 18 citations